Donor substance use and lung transplantation: A single center experience

Liu, C.; Heid, Christopher A.; Hauptmann, Edward; Ali, Mir H.; Pruszynski, Jessica; Pillai, Ananya; Banga, Amit; Wait, Michael A.; Huffman, Lynn C.; Peltz, Matthias; Hackmann, Amy E.; Jessen, Michael E.; Ring, W. Steves; Murala, John Santosh Kumar

doi:10.1016/j.tpr.2022.100124

Search citation statements

Order By: Relevance

Paper Sections

Select...

Donor Risk Factors For Development Of Pgd1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 51 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This group examined donor cocaine, opioid, methamphetamine, and cannabis use along with their effect on recipient outcomes post-transplantation and did not find a significant difference in development of PGD or overall survival. There was, however, an increased probability of developing PGD when the donor was a smoker ( 50 ). The temporality of smoking has also been postulated as contributing to the development of PGD and adverse outcomes.…”

Section: Donor Risk Factors For Development Of Pgdmentioning

confidence: 99%

Donor and recipient risk factors for the development of primary graft dysfunction following lung transplantation

Jenkins,

Verdiner,

Omar

et al. 2024

Front. Immunol.

View full text Add to dashboard Cite

Primary Graft Dysfunction (PGD) is a major cause of both short-term and long-term morbidity and mortality following lung transplantation. Various donor, recipient, and technical risk factors have been previously identified as being associated with the development of PGD. Here, we present a comprehensive review of the current literature as it pertains to PGD following lung transplantation, as well as discussing current strategies to mitigate PGD and future directions. We will pay special attention to recent advances in lung transplantation such as ex-vivo lung perfusion, thoracoabdominal normothermic regional perfusion, and up-to-date literature published in the interim since the 2016 ISHLT consensus statement on PGD and the COVID-19 pandemic.

show abstract

Section: Donor Risk Factors For Development Of Pgdmentioning

confidence: 99%